Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.
Also called NCT06121518
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 235 participants
- Registry
-
NCT06121518
-
- Other papers using this trial's data
- Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06121518. Randomized; double masking; primary purpose treatment. Start 2023-07-31 (actual); primary completion 2024-03-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
- Condition
- Essential Hypertension
- Intervention (Drug)
- D064 and D702, QD
- Intervention (Drug)
- D064 and Placebo of D702, QD
- Intervention (Drug)
- Placebo of D064 and D702, QD
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct06121518- Content hash
95b2bc7fcb3a145d1a22c11839f1794ee0b3987e969c4b420dff8dfe432b7422